SEARCH:   Advanced

Blood, 1 October 2005, Vol. 106, No. 7, pp. 2231-2232. This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Dimmeler, S. Search for Related Content PubMed Articles by Dimmeler, S. Related Collections Related Article in Blood Online Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  HEMOSTASIS Comment on Elsheikh et al, page 2347 Circulating endothelial precursors: identification of functional subpopulations Stefanie Dimmeler UNIVERSITY OF FRANKFURT The characterization of circulating endothelial progenitor cells is unclear. A recent study now provides evidence that the expression of the VEGF receptor 2 identifies a subpopulation of cells with endothelial regeneration activity within the CD14+ monocytic cells. Endothelial progenitor cells (EPCs) contribute to neovascularization after ischemia, tumorangiogenesis, and recovery of the endothelial monolayer after injury. Infusion of bone marrow-derived or circulating EPC augments neovascularization (for review, see Urbich and Dimmeler1). However, the precise characterization of EPCs is still an open question. Increasing evidence suggests that different subsets of EPCs exist within the circulating blood. Cells with endothelial surface marker expression and functional characteristics of endothelial cells can be grown out of hematopoietic stem cells expressing the markers CD34 or CD133, but also from monocytic cells. View larger version (22K): [in this window] [in a new window]   Different features of CD14+ subpopulations.   In this issue of Blood, Elsheikh and colleagues aimed to define the subpopulation within the monocytic cells, which exerts "EPC quality." The authors isolated CD14+ monocytic cells and purified the cells that expressed the vascular endothelial growth factor receptor 2 (VEGF-R2, or KDR). Expression of endothelial marker proteins and functional activity of the isolated cells was then determined. CD14+VEGF-R2+ cells express higher levels of endothelial marker proteins and formed tubes in vitro (see figure). Moreover, CD14+VEGF-R2+ but not CD14+ VEGF-R2- cells contributed to re-endothelialization after infusion of the cells in mice after denuding injury. These results are in accordance with previous studies demonstrating that CD34+VEGF-R2+ cells showed a better improvement of neovascularization after hind-limb ischemia compared with CD34+VEGF-R2- cells.2 These data implicate that VEGF-R2 expression is a major criterion to identify cells with a capacity to generate endothelial cells independent of whether they originate directly from hematopoietic stem cells or from monocytic cells. One may speculate that the expression of VEGF-R2 is simply required to mediate signalling induced by its ligand, VEGF. However, CD14+VEGF-R+ as well as CD34+VEGF-R2+ also exhibited additional functional features. VEGF-R2+ cells showed a higher proliferation, migration, and growth factor release,2 (see figure) indicating that selection of VEGF-R2+ cells may enrich cells with a specific functional profile and potential "stemness" features. Indeed, pluripotent stem cells were restricted to the CD34+VEGF-R2+-cell fraction.3 Moreover, a specific subfraction of circulating CD14+ monocytic cells was recently shown to express the stem-cell markers Nanog and octamer-binding transcription factor 4 (oct-4).4 These Nanog+ monocytic cells were enriched in the VEGF-R2+ fraction and showed low expression of CD34. Whether these CD14+/CD34low/Nanog+ cells are representing the active fraction of CD14+/VEGF-R2+ cells isolated by Elsheikh et al remains to be elucidated. References Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95: 343-353.[Abstract/Free Full Text] Madeddu P, Emanueli C, Pelosi E, et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J. 2004;18: 1737-1739.[Abstract/Free Full Text] Ziegler BL, Valtieri M, Porada GA, et al. KDR receptor: a key marker defining hematopoietic stem cells. Science. 1999;285: 1553-1558.[Abstract/Free Full Text] Romagnani P, Annunziato F, Liotta F, et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. Prepublished on July 14, 2005. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? Related Article in Blood Online: Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity Elzafir Elsheikh, Mehmet Uzunel, Zhong He, Jan Holgersson, Grzegorz Nowak, and Suchitra Sumitran-Holgersson Blood 2005 106: 2347-2355. [Abstract] [Full Text] [PDF] This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Dimmeler, S. Search for Related Content PubMed Articles by Dimmeler, S. Related Collections Related Article in Blood Online Social Bookmarking                   What's this?

	Blood Online is supported in part by Genentech BioOncology and Biogen Idec
	Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020